JPMorgan prices capped notes with 8.10% cap
JPMorgan Chase Financial Company LLC is offering capped notes linked to the lesser performing of the Russell 2000® and the S&P 500®.
Rhea-AI Filing Summary
JPMorgan Chase Financial Company LLC is offering capped notes linked to the lesser performing of the Russell 2000® and the S&P 500®. The notes have a Participation Rate of 100.00%, a stated Maximum Amount of at least $81.00 per $1,000 (an 8.10% cap), an expected pricing date of on or about May 27, 2026, expected settlement of on or about June 1, 2026, an Observation Date of June 28, 2027 and a Maturity Date of July 1, 2027 subject to postponement. At maturity each note will pay principal plus an Additional Amount equal to $1,000 × Lesser Performing Index Return × 100.00%, floored at zero and capped at the Maximum Amount. The estimated value at issuance is shown as $990.70 per $1,000 and will not be less than $900.00 per $1,000 when set. Selling commissions will not exceed $5.00 per $1,000. Payments are unsecured obligations of JPMorgan Chase Financial Company LLC and are fully and unconditionally guaranteed by JPMorgan Chase & Co.; payments remain subject to the credit risk of both entities.
Positive
- None.
Negative
- None.
Insights
Capped-note offers trade capped upside for principal protection tied to the weaker of two indices.
The notes pay principal at maturity plus an Additional Amount based on the Lesser Performing Index Return multiplied by a 100.00% Participation Rate, subject to a Maximum Amount of at least $81.00 per $1,000. The structure provides upside limited to the cap and no downside cushion beyond return of principal, exposing investors to index declines and issuer credit risk.
Key dependencies are the Lesser Performing Index level at the Observation Date: June 28, 2027, the final priced Maximum Amount shown in the pricing supplement, and the creditworthiness of JPMorgan Financial and JPMorgan Chase & Co.. Secondary market liquidity and JPMS repurchase practices will affect realized exit prices before maturity.
Issuer expects to treat the notes as contingent payment debt instruments for U.S. federal tax purposes.
The pricing supplement states the issuer intends CPDI treatment and to determine a comparable yield and projected payment schedule at pricing; this determination will govern OID accruals and annual tax treatment for U.S. holders unless the IRS successfully challenges it. The issuer may adopt a different treatment at pricing.
Investors should consult tax advisers because the final tax treatment, the comparable yield, and potential Section 871(m) implications for Non-U.S. holders will be provided in the pricing supplement filed at issuance.
Key Figures
Key Terms
Contingent Payment Debt Instruments tax
Internal funding rate financial
Participation Rate financial
Additional Amount financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is being offered in the JPM 424B2 pricing supplement?
When will JPM’s capped notes price, settle, observe and mature?
How is the maturity payment on the JPM notes calculated?
What are the credit and liquidity considerations for JPM capped notes?
What is the estimated value and fees disclosed for these notes?
AI-generated analysis. How Rhea-AI works. Not financial advice.